• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Homeobox protein GBX-2 (GBX2)

ACP22802

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP22802 Target NameGBX2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-348Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP52951
Background Information
  • Uniprot Id

    P52951

  • Target Species

    Human

  • Target Name

    GBX2

  • Target Full Name

    Homeobox protein GBX-2

  • Target Function

    May act as a transcription factor for cell pluripotency and differentiation in the embryo.

  • Target Subcellular Location

    Nucleus.

  • Target Synonyms

    Gastrulation and brain-specific homeobox protein 2; Gastrulation brain homeo box 2; Gastrulation brain homeobox 2; gbx2; GBX2_HUMAN; Homeobox protein GBX 2 ; Homeobox protein GBX-2; Homeobox protein GBX2; Homeobox protein STRA7; Mmoxa

  • Target Background

    Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of nervous system development and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; nervous system development; and neural crest cell migration. Predicted to be part of chromatin. Predicted to be active in nucleus.

Inquire Recombinant Human Homeobox protein GBX-2 (GBX2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification